Gabay, C., Msihid, J., Zilberstein, M., Paccard, C., Lin, Y., Graham, N. M. H., & Boyapati, A. (2018). Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: A biomarker substudy of the phase 3 TARGET study. RMD Open.

Gabay, Cem, Jérôme Msihid, Moshe Zilberstein, Caroline Paccard, Yong Lin, Neil M H. Graham, و Anita Boyapati. "Identification of Sarilumab Pharmacodynamic and Predictive Markers in Patients With Inadequate Response to TNF Inhibition: A Biomarker Substudy of the Phase 3 TARGET Study." RMD Open 2018.

Gabay, Cem, et al. "Identification of Sarilumab Pharmacodynamic and Predictive Markers in Patients With Inadequate Response to TNF Inhibition: A Biomarker Substudy of the Phase 3 TARGET Study." RMD Open 2018.